Brief: Crossject: First Injections Of ZENEO Midazolam For Clinical Bioequivalence Study

Crossject SA

24/05/2022 17:36

May 24 (Reuters) - Crossject SA  74C.F :
    * FIRST INJECTIONS OF ZENEO MIDAZOLAM FOR THE CLINICAL
BIOEQUIVALENCE STUDY
    * COMPLETE RESULTS OF THE BIOEQUIVALENCE STUDY ARE EXPECTED
IN
AUTUMN

Source text for Eikon:  urn:newsml:reuters.com:*:nGNE2t7lVX
Further company coverage:  74C.F ,  ALCJ.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 772 09 20;))